‘OUR GOAL WAS TO … HAVE AN EFFECT’ — A wave of Republican-led states have restricted care for children with gender dysphoria, and they’re turning to Dr. Stanley Goldfarb and his organization, Do No Harm, for legislative strategy and hand-picked medical experts, POLITICO’s Daniel Payne reports. Goldfarb, a former dean at the University of Pennsylvania’s medical school and a retired kidney doctor, has become a go-to source of medical information in making the case to restrict gender-affirming care. The group has argued that puberty blockers, rare surgeries and hormone treatments are medically harmful. Half of states have enacted laws restricting access to such care. “Our goal right from the beginning was to have an effect,” Goldfarb, who has raised millions for the cause since he founded the group in 2022, told POLITICO. “We’ve done that.” Goldfarb and his group have bucked the medical consensus from established organizations like the American Medical Association and the American Academy of Pediatrics, which have published policies backed with research to show that gender-affirming care is safe and necessary for patients’ health. Goldfarb accuses the establishment of putting ideology ahead of good medicine. The pushback: Goldfarb, who acknowledges his training as a kidney doctor means he’s no expert in gender care, and his work with the right have caught the eye of doctors leading established groups. Dr. Marci Bowers, president of the World Professional Association for Transgender Health who provides gender-affirming care to others, calls Goldfarb “pompous” and compares his crusade against the care to Nazi eugenics experiments. Goldfarb called Bowers’ broadside, or any name-calling in the debate over transgender care, “the last refuge of the scoundrel.” Lobbyists for mainstream health care organizations are worried about the group's influence among the GOP and believe his lobbying on gender-affirming care is putting patients at risk. “Banning things rarely ends well,” said Dr. Deborah Greenhouse, a pediatrician who works in South Carolina, which has barred patients under 18 from getting medical care for gender transition. What’s else is ahead: Goldfarb’s ambitions go beyond gender-affirming care, eyeing rooting out diversity, equity and inclusion efforts in medical education. Without Goldfarb, Rep. Greg Murphy (R-N.C.) said, the lawmakers “would not have made any significant progress” on his bill pending before the House Committee on Education and the Workforce. Whether Congress passes a bill or not, Goldfarb sees DEI as a ripe target after the Supreme Court banned affirmative action in college admissions last year. WELCOME TO MONDAY PULSE. Our politics team has the latest coverage on the Trump assassination attempt at politico.com. Send your tips, scoops and feedback to bleonard@politico.com and ccirruzzo@politico.com and follow along @_BenLeonard_ and @ChelseaCirruzzo.
|